Log in to see the prices.
The price above is a net price.
The Tick-borne Disease Panel (qPCR) product is used to detect sequences specific to pathogens causing tick-borne diseases (Borrelia, Babesia and Bartonella henselae) in DNA preparations obtained from ticks and material collected from animals.
Kit size: 100 markers
Reaction_1: triplex (FAM: Lyme Disease Borrelia group, HEX: internal control, Texas Red: Bartonella henselae)
Reaction_2: triplex (FAM: Lyme Disease Borrelia group, HEX: internal control, Texas Red: Bartonella henselae)
Internal control: exogenous/endogenous
Determination: qualitative/quantitative
Kit components:
Tick-borne diseases are an increasingly common health problem for humans and animals in many regions of the world. They are caused by various pathogens, such as bacteria, viruses, and protozoa, and the course of the disease can range from mild to life-threatening. One of the best-known tick-borne diseases is Lyme disease. It is caused by bacteria of the genus Borrelia (Lyme Disease Borrelia), which can lead to chronic neurological, joint, and skin disorders.
Increasing attention is also being paid to protozoa of the genus Babesia, which attack red blood cells and can cause malaria-like symptoms, particularly dangerous for people with compromised immune systems. It is also worth mentioning the bacterium Bartonella henselae, known mainly for cat scratch disease is also transmitted by certain species of ticks. The symptoms of tick-borne diseases are varied and often nonspecific, which can make diagnosis difficult. Therefore, proper diagnosis is crucial, as it allows for rapid detection of the pathogen and implementation of appropriate treatment.
The Tick-borne Disease Panel (qPCR) product allows for the detection of four tick-borne pathogens:
The above pathogens can be detected qualitatively. They are detected in two triplex reactions. Each reaction is used to detect two types of pathogens and an exogenous internal control.
